Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function
- PMID: 8662993
Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function
Abstract
Thrombin receptor and proteinase-activated receptor 2 (PAR2) define a family of G protein-coupled receptors that are activated by a novel proteolytic mechanism. Specific cleavage of their amino-terminal exodomains unmasks a new amino terminus which then serves as a tethered ligand, docking intramolecularly to the body of the receptor to effect signaling. Identification of the docking interactions between tethered ligand domain and receptor is critical for understanding transmembrane signaling by these receptors. Synthetic "agonist peptides" that mimic the tethered ligand domains of thrombin receptor and PAR2 act as agonists at their respective receptors. Toward defining the docking interactions which mediate receptor activation, we determined the specificity of the thrombin receptor and PAR2 for their respective agonist peptides and used receptor chimeras to identify the receptor domains responsible for such specificity. PAR2 responded to both thrombin receptor and PAR2 agonist peptides. In contrast, thrombin receptor was selective for its own agonist peptide. Substitution of the extracellular face of PAR2, its amino-terminal exodomain and three extracellular loops, for the cognate thrombin receptor structures yielded a chimeric receptor with PAR2-like agonist specificity. Substitution of individual extracellular domains revealed that the primary determinant of agonist specificity was extracellular loop 2. Strikingly, substitution of either the amino-terminal exodomain or third extracellular loop alone caused marked loss of receptor function, but the double substitution yielded a functional receptor. Thus, the extracellular domains of these G protein-coupled receptors are more than simply passive links between transmembrane domains. They participate in agonist recognition and must interact, directly or indirectly, for proper receptor function.
Similar articles
-
Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site.J Biol Chem. 1995 Sep 15;270(37):21619-25. doi: 10.1074/jbc.270.37.21619. J Biol Chem. 1995. PMID: 7665575
-
Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.Can J Physiol Pharmacol. 1997 Jul;75(7):832-41. Can J Physiol Pharmacol. 1997. PMID: 9315351
-
Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster.Mol Med. 1996 May;2(3):349-57. Mol Med. 1996. PMID: 8784787 Free PMC article.
-
How the protease thrombin talks to cells.Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11023-7. doi: 10.1073/pnas.96.20.11023. Proc Natl Acad Sci U S A. 1999. PMID: 10500117 Free PMC article. Review.
-
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.Am J Physiol. 1998 Jun;274(6):C1429-52. doi: 10.1152/ajpcell.1998.274.6.C1429. Am J Physiol. 1998. PMID: 9696685 Review.
Cited by
-
The effects of phototherapy and melanocytes on keratinocytes.Exp Ther Med. 2018 Apr;15(4):3459-3466. doi: 10.3892/etm.2018.5807. Epub 2018 Jan 30. Exp Ther Med. 2018. PMID: 29545869 Free PMC article.
-
Allosteric modulation of protease-activated receptor signaling.Mini Rev Med Chem. 2012 Aug;12(9):804-11. doi: 10.2174/138955712800959116. Mini Rev Med Chem. 2012. PMID: 22681248 Free PMC article. Review.
-
Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases.Thromb J. 2019 Mar 29;17:4. doi: 10.1186/s12959-019-0194-8. eCollection 2019. Thromb J. 2019. PMID: 30976204 Free PMC article. Review.
-
Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational Modeling.ACS Pharmacol Transl Sci. 2018 Oct 16;1(2):119-133. doi: 10.1021/acsptsci.8b00019. eCollection 2018 Nov 9. ACS Pharmacol Transl Sci. 2018. PMID: 32219208 Free PMC article.
-
Transient receptor potential channels in pain and inflammation: therapeutic opportunities.Pain Pract. 2010 May-Jun;10(3):185-200. doi: 10.1111/j.1533-2500.2010.00358.x. Epub 2010 Mar 2. Pain Pract. 2010. PMID: 20230457 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources